Why Listening to Patient Organizations is Key in Drug Development
As the biotech industry flourishes and therapies become more targeted and personalized, the need for…
As the biotech industry flourishes and therapies become more targeted and personalized, the need for…
A phase I/II trial run by the Dutch company ProQR has found that its RNA…
What does it take to be a successful biotech entrepreneur? I put this and other…
Dutch company ProQR has released data from a Phase I/II trial showing its RNA therapy…
ProQR is the result of a personal quest against cystic fibrosis started by its CEO,…
ProQR has received €6M from the American charity, Foundation Fighting Blindness, for the development of its…
Galapagos and ProQR will work together to target fibrosis using a technology to treat genetic…
The EMA has granted orphan drug designation to ProQR's QR-313, a possible first disease-modifying treatment…
ProQR is aiming to raise funds for clinical trials on the Nasdaq despite the fact…
Evelyn chatted with Thomas de Vlaam to find out what his company, Amylon, is working…
ProQR has spun out Amylon Therapeutics, a company that will treat central nervous system disorders…
Known for its charming canals and tulip fields, Leiden is a major tourist attraction in…